Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis

Modern Rheumatology

Volumn 19, Issue 5, 2009, Pages 530-535

  Kuwana, Masataka ^a   Okazaki, Yuka ^a   Kaburaki, Junichi ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Akasaka Mental Clinic   (Japan)

Author keywords

Digital ulcer; Endothelial progenitor cell; Raynaud's phenomenon; Scleroderma; Statins

Indexed keywords

ATORVASTATIN; BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL SELECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL ULCER; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HAND DISEASE; HEALTH STATUS; HUMAN; HUMAN CELL; LONG TERM CARE; PATIENT ASSESSMENT; PILOT STUDY; PLEIOTROPY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RAYNAUD PHENOMENON; STEM CELL; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; UPREGULATION; VASCULAR DISEASE; VISUAL ANALOG SCALE;

AGED; ANALYSIS OF VARIANCE; ANTICHOLESTEREMIC AGENTS; CELL COUNT; CELL SEPARATION; DISEASE PROGRESSION; E-SELECTIN; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEALTH STATUS; HEPTANOIC ACIDS; HUMANS; IMMUNOPRECIPITATION; MIDDLE AGED; PROSPECTIVE STUDIES; PYRROLES; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; STEM CELLS; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70350011911     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0199-4     Document Type: Article

References (23)

1. Guiducci S, Giacomelli R, Matucci-Cerinic M. Vascular complications of scleroderma. Autoimmun Rev. 2007;6:520-3.
2. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet. 2004;364:603-10.
3. Caplice NM, Doyle B. Vascular progenitor cells: Origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis. Stem Cells Dev. 2005;14:122-39.
4. Kuwana M. Potential benefit of statins for vascular disease in systemic sclerosis. Curr Opin Rheumatol. 2006;18:594-600.
5. Zhou Q, Liao JK. Statins and cardiovascular diseases: From cholesterol lowering to pleiotropy. Curr Pharm Des. 2009;15:467-78.
6. Kuwana M, Kaburaki J, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum. 2006;54:1946-51.
7. Abou-Raya A, Abou-Raya S, Helmii M. Statins: Potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers. J Rheumatol. 2008;35:1801-8.
8. Masi AT, Rodnan GP, Medsger TA Jr, Altman RD, D'Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-90.
9. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum. 2002;46:2410-20.
10. Clements PJ, Lachenbruch PA, Seibold JR, White B, Weiner S, Martin RW, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281-5.
11. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 1994;37:75-83.
12. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34 + cells identifies a population of functional endothelial precursors. Blood. 2000;95:952-8.
13. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, et al. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis. 2009;68:163-8.
14. Del Papa N, Cortiana M, Vitali C, Silvestris I, Maglione W, Comina DP, et al. Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis. J Rheumatol. 2008;35:1323-8.
15. Furukawa S, Yasuda S, Amengual O, Horita T, Atsumi T, Koike T. Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: A pilot study. Ann Rheum Dis. 2006;65:1118-20.
16. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000;6:1004-10.
17. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001;108:391-7.
18. Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest. 2001;108:399-405.
19. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, et al. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002;105:3017-24.
20. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 2006;54:2605-15.
21. Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, et al. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: New insight into the pathogenesis of systemic sclerosis. Arthritis Rheum. 2007;56:1994-2004.
22. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-7.
23. Zhu S, Evans S, Yan B, Povsic TJ, Tapson V, Goldschmidt-Clermont PJ, et al. Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation. 2008;118:2156-65.